View all news

Eating Mushrooms May Help Lower Prostate Cancer Risk

09/06/2019

A new study published in the International Journal of Cancer found an inverse relationship between mushroom consumption and the development of prostate cancer among middle-aged and elderly Japanese men, suggesting that regular mushroom intake might help to prevent prostate cancer.

A new study published in the International Journal of Cancer found an inverse relationship between mushroom consumption and the development of prostate cancer among middle-aged and elderly Japanese men, suggesting that regular mushroom intake might help to prevent prostate cancer.

A total of 36,499 men, aged 40 to 79 years who participated in the Miyagi Cohort Study in 1990 and in the Ohsaki Cohort Study in 1994 were followed for a median of 13.2 years. During follow-up, 3.3% of participants developed prostate cancer. Compared with mushroom consumption of less than once per week, consumption once or twice a week was associated with an 8% lower risk of prostate cancer and consumption three or more times per week was associated with a 17% lower risk.

“Since information on mushroom species was not collected, it is difficult to know
which specific mushroom(s) contributed to our findings. Also, the mechanism of the beneficial effects of mushrooms on prostate cancer remains uncertain,” said lead author Shu Zhang, PhD, of the Tohoku University School of Public Health, in Japan.

Additional Information

Link to Study: https://onlinelibrary.wiley.com/doi/10.1002/ijc.32591

About Journal 

The International Journal of Cancer (IJC) is the official journal of the Union for International Cancer Control—UICC; it appears twice a month. IJC invites submission of manuscripts under a broad scope of topics relevant to experimental and clinical cancer research and publishes original Research Articles and Short Reports under the following categories:

  • Cancer Epidemiology
  • Cancer Genetics and Epigenetics
  • Infectious Causes of Cancer
  • Molecular Cancer Biology
  • Tumor Immunology and Microenvironment
  • Tumor Markers and Signatures
  • Cancer Therapy and Prevention

 

About Wiley

 

Wiley drives the world forward with research and education. Through publishing, platforms and services, we help students, researchers, universities, and corporations to achieve their goals in an ever-changing world. For more than 200 years, we have delivered consistent performance to all of our stakeholders. The Company's website can be accessed at www.wiley.com.

Penny Smith +44 (0) 1243 770448 (UK)
newsroom@wiley.com

Multimedia Files:

View all news